Patent · US Active

Methods of treating cognitive decline with transforming growth factor beta inhibitors

US10668049B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignees

The Regents of the University of California · US
Ben-Gurion University of the Negev · IL

Inventors

Daniela Kaufer · Kiryat Ono, IL
Alon Friedman · Ramat HaSharon, IL
Luisa Cacheaux · Berkeley, US

Key dates

Filing date	Sep 7, 2016
Grant date	Jun 2, 2020
Priority date	—
Expiry date	Sep 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides methods of treating epilepsy and other neurological disorders. The methods generally involve administering to an individual in need thereof an effective amount of an agent that blocks a transforming growth factor-beta pathway.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.